[Hormontal treatment of pre-tumorous diseases of the testis in rats].
Tumours and proliferates of the testes from spermatogenic epithelium were treated with estrogens, and those from the interstitial cells-with androgens and 17-hydrosyprogesterone caproate. Depression of the folliculo-stimulating function of the pituitary body with a simultaneous stimulation of the luteinizing hormones (LH) production under the effect of estrogen led to cessation of teratoma and seminoma growth, and to the resolution of the proliferates. When androgens or 17-hydroxyprogesterone caproate were used, depression of the LH led to cessation of the tumour growth, and to the resolution of proliferion of proliferates from the interstitial cells.
D000818:Animals; D004054:Diethylstilbestrol / Q000627:therapeutic use; D004407:Dysgerminoma / Q000188:drug therapy*; D012739:Gonadal Steroid Hormones / Q000627:therapeutic use*; D006589:Hexestrol / Q000627:therapeutic use; D006908:Hydroxyprogesterones / Q000627:therapeutic use; D007984:Leydig Cell Tumor / Q000188:drug therapy*; D008297:Male; D008777:Methyltestosterone / Q000627:therapeutic use; D011230:Precancerous Conditions / Q000188:drug therapy; D051381:Rats; D013724:Teratoma / Q000188:drug therapy*; D013736:Testicular Neoplasms / Q000188:drug therapy*; D013739:Testosterone / Q000627:therapeutic use
D012739:Gonadal Steroid Hormones; D006908:Hydroxyprogesterones; D006589:Hexestrol; D013739:Testosterone; D004054:Diethylstilbestrol; D008777:Methyltestosterone
Gormonal'noe lechenie predopukholevykh zabolevaniĭ iaichka u krys